Erdafitinib

Generic name: Erdafitinib
Brand names: Balversa
Dosage form: oral tablet (3 mg; 4 mg; 5 mg)
Drug class: Multikinase inhibitors

Usage of Erdafitinib

Erdafitinib is used in adults to treat bladder cancer that has spread to other parts of the body (metastatic), or cannot be removed with surgery.

Erdafitinib is used if your cancer has a specific genetic marker (an abnormal "FGFR" gene), and if you were treated with at least one other platinum cancer medicine that did not work or has stopped working. Your doctor will test you for this gene.

Erdafitinib is usually given after other treatments have failed.

Erdafitinib was approved by the US Food and Drug Administration (FDA) on an "accelerated" basis. In clinical studies, some people responded to erdafitinib, but further studies are needed.

Erdafitinib may also be used for purposes not listed in this medication guide.

Erdafitinib side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

You may have high phosphate levels, and your blood will need to be tested often. Tell your doctor if you have symptoms such as numbness or tingling around your mouth, muscle stiffness, body aches, itching or rash, tiredness, trouble sleeping, nausea, vomiting, loss of appetite, or feeling short of breath.

Erdafitinib may cause serious side effects. Call your doctor at once if you have:

vision problems, vision loss;

eye pain or redness; or

problems with your fingernails or toenails--pain, bleeding, separation of the nails from the skin (nail bed), unusual breakage, changes in nail color or texture, cracks or infection in your cuticles.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects of erdafitinib may include:

dry eyes;

dry mouth, mouth sores;

hair loss;

dry skin, problems with your fingernails or toenails;

redness, swelling, pain, or blisters on the palms of your hands or the soles of your feet;

muscle pain;

feeling tired;

abnormal liver or kidney function tests;

low sodium levels, low red blood cell count;

nausea, stomach pain, loss of appetite;

diarrhea, constipation; or

changes in your sense of taste.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Erdafitinib

Tell your doctor if you have ever had problems with your eyes or vision.

You may need to have a negative pregnancy test before starting this treatment.

Both men and women using erdafitinib should use effective birth control to prevent pregnancy. Erdafitinib can harm an unborn baby or cause birth defects if the mother or father is using this medicine.

Keep using birth control for at least 1 month after your last dose. Tell your doctor right away if a pregnancy occurs while either the mother or the father is using erdafitinib.

Do not breastfeed while using this medicine, and for at least 1 month after your last dose.

It may be harder for you to get pregnant while you are using this medicine. You should still use birth control to prevent pregnancy because the medicine can harm an unborn baby.

Relate drugs

How to use Erdafitinib

Usual Adult Dose for Urothelial Carcinoma:

8 mg orally once daily; increase to 9 mg orally once daily based on serum phosphate levels and tolerability at 14 to 21 days until disease progression or unacceptable toxicityComments-Select patients for therapy based on the presence of susceptible FGFR genetic alterations in tumor specimens as detected by an FDA-approved companion diagnostic.Use: For the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (mUC), that has susceptible FGFR3 or FGFR2 genetic alterations, and progressed during or following at least one line of prior platinum-containing chemotherapy, including within 12 months of neoadjuvant or adjuvant platinum-containing chemotherapy.

Warnings

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

What other drugs will affect Erdafitinib

Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase side effects or make the medicines less effective.

Tell your doctor about all your other medicines, especially:

medicines that may change phosphate levels--potassium phosphate supplements, vitamin D supplements, antacids, enemas or laxatives that contain phosphate, and other medicines known to contain phosphate.

Other drugs may affect erdafitinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.